Rapid protection against viral infections by chemokine-accelerated post-exposure vaccination

Prophylactic vaccines generate strong and durable immunity to avoid future infections, whereas post-exposure vaccinations are intended to establish rapid protection against already ongoing infections. Antiviral cytotoxic CD8 T cells (CTL) are activated by dendritic cells (DCs), which themselves must...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology 2024, Vol.15, p.1338499-1338499
Main Authors: Heine, Annkristin, Lemmermann, Niels A W, Flores, Chrystel, Becker-Gotot, Janine, Garbi, Natalio, Brossart, Peter, Kurts, Christian
Format: Article
Language:English
Subjects:
chemokines
CTL induction
Immunology
murine cytomegalovirus
NKT cells
post-exposure vaccination
viral infection
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Prophylactic vaccines generate strong and durable immunity to avoid future infections, whereas post-exposure vaccinations are intended to establish rapid protection against already ongoing infections. Antiviral cytotoxic CD8 T cells (CTL) are activated by dendritic cells (DCs), which themselves must be activated by adjuvants to express costimulatory molecules and so-called signal 0-chemokines that attract naive CTL to the DCs. Here we asked whether a vaccination protocol that combines two adjuvants, a toll-like receptor ligand (TLR) and a natural killer T cell activator, to induce two signal 0 chemokines, synergistically accelerates CTL activation. We used a well-characterized vaccination model based on the model antigen ovalbumin, the TLR9 ligand CpG and the NKT cell ligand -galactosylceramide to induce signal 0-chemokines. Exploiting this vaccination model, we studied detailed T cell kinetics and T cell profiling in different mouse models of viral infection. We found that CTL induced by both adjuvants obtained a head-start that allowed them to functionally differentiate further and generate higher numbers of protective CTL 1-2 days earlier. Such signal 0-optimized post-exposure vaccination hastened clearance of experimental adenovirus and cytomegalovirus infections. Our findings show that signal 0 chemokine-inducing adjuvant combinations gain time in the race against rapidly replicating microbes, which may be especially useful in post-exposure vaccination settings during viral epi/pandemics.
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2024.1338499